TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Alfresa Holdings ( (JP:2784) ).
Alfresa Holdings Corporation announced a revision to its performance-linked stock compensation plan as it transitions to a company with an audit and supervisory committee structure. This change aims to align the interests of directors and executive officers with shareholders by using a Board Incentive Plan trust to grant shares based on performance. The revision is subject to approval at the upcoming shareholders meeting and includes additional contributions to the trust, enhancing transparency and independence in remuneration decisions.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2120.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare industry, focusing on pharmaceutical distribution and manufacturing. The company provides a range of healthcare products and services, primarily targeting the Japanese market.
Average Trading Volume: 511,221
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen414.9B
For an in-depth examination of 2784 stock, go to TipRanks’ Stock Analysis page.